Sign in
4

Changes in Ownership

IONIS PHARMACEUTICALS INC Filed Acc 0000874015-26-000134

EVP, Chief Scientific Officer sold 85,089 shares at an average $79.23 ($6,741,669)

  • EVP, Chief Scientific Officer acquired 65,089 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

BENNETT C FRANK · EVP, Chief Scientific Officer

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2026-03-03 Exercise or conversion : show line 1 in the form 10b5-1 +16,463 $32.60 $536,694 117,017 D
2026-03-03 Exercise or conversion : show line 2 in the form 10b5-1 +48,626 $60.89 $2,960,837 165,643 D
2026-03-03 Sale : show line 3 in the form 10b5-1 −71,600 $79.10 $5,663,488 94,043 D
2026-03-03 Sale : show line 4 in the form 10b5-1 −12,687 $79.88 $1,013,410 81,356 D
2026-03-03 Sale : show line 5 in the form 10b5-1 −802 $80.76 $64,771 80,554 D
Open-market sales · 85,089 sh · avg $79.23 · $6,741,669

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-03-03 Exercise or conversion : show line 6 in the form 10b5-1 Non-Qualified Stock Option (right to buy) −16,463 2,406 D
2026-03-03 Exercise or conversion : show line 7 in the form 10b5-1 Non-Qualified Stock Option (right to buy) −48,626 0 D
Loading xslF345X05/edgardoc.xml…